APREMILAST — all Canadian products
23 DINs
19 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is APREMILAST, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02571021 | ACCEL-APREMILAST | ACCEL PHARMA INC | Tablet | Oral | APREMILAST 30 MG | Approved | |
| 02538172 | APO-APREMILAST | APOTEX INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Approved | |
| 02538180 | APO-APREMILAST | APOTEX INC | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02541661 | APO-APREMILAST TABLETS | APOTEX INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Approved | |
| 02541688 | APO-APREMILAST TABLETS | APOTEX INC | Tablet | Oral | APREMILAST 30 MG | Approved | |
| 02524120 | AURO-APREMILAST | AURO PHARMA INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Marketed | |
| 02524104 | AURO-APREMILAST | AURO PHARMA INC | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02524112 | AURO-APREMILAST | AURO PHARMA INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Approved | |
| 02518929 | GLN-APREMILAST | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Approved | |
| 02518910 | GLN-APREMILAST | GLENMARK PHARMACEUTICALS CANADA INC. | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02528959 | JAMP APREMILAST | JAMP PHARMA CORPORATION | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02528967 | JAMP APREMILAST | JAMP PHARMA CORPORATION | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Marketed | |
| 02528347 | MAR-APREMILAST | MARCAN PHARMACEUTICALS INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Approved | |
| 02528355 | MAR-APREMILAST | MARCAN PHARMACEUTICALS INC | Tablet | Oral | APREMILAST 30 MG | Approved | |
| 02434318 | OTEZLA | AMGEN CANADA INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Marketed | |
| 02434334 | OTEZLA | AMGEN CANADA INC | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02521733 | PMS-APREMILAST | PHARMASCIENCE INC | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02529092 | SANDOZ APREMILAST | SANDOZ CANADA INCORPORATED | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Marketed | |
| 02529084 | SANDOZ APREMILAST | SANDOZ CANADA INCORPORATED | Tablet | Oral | APREMILAST 30 MG | Marketed | |
| 02525747 | MINT-APREMILAST | MINT PHARMACEUTICALS INC | Tablet | Oral | APREMILAST 30 MG | Dormant | |
| 02521725 | PMS-APREMILAST | PHARMASCIENCE INC | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Cancelled Pre Market | |
| 02517493 | TEVA-APREMILAST | TEVA CANADA LIMITED | Tablet | Oral | APREMILAST 30 MG | Cancelled Pre Market | |
| 02517485 | TEVA-APREMILAST | TEVA CANADA LIMITED | Tablet | Oral | APREMILAST 10 MG; APREMILAST 20 MG; APREMILAST 30 MG | Cancelled Pre Market |
Browse other molecules: